Clinical Report: Influence of Previous COVID-19 Infection on Coronary Slow Flow Rates

Overview

This study reveals a significantly higher prevalence of coronary slow flow (CSF) in patients with unstable angina who have a history of COVID-19 compared to those without. The findings suggest ongoing microvascular dysfunction in individuals recovering from COVID-19.

Background

Coronary slow flow (CSF) is associated with anginal symptoms and normal coronary arteries, indicating microvascular dysfunction. Understanding the impact of COVID-19 on CSF is crucial, as it may contribute to long-term cardiovascular complications in recovering patients. This research highlights the need for awareness of CSF in the context of post-COVID-19 care.

Data Highlights

Key Findings

• CSF prevalence was 18.9% in the COVID (+) UA-NCA cohort versus 5.3% in the COVID (–) UA-NCA cohort (p = 0.003).
• Corrected TIMI frame count (CTFC) for LAD was significantly higher in the COVID (+) group (26.1 ± 4.3) compared to the COVID (–) group (22.4 ± 2.6, p = 0.01).
• CTFC for LCX was also higher in the COVID (+) cohort (24.3 ± 4.5) versus the COVID (–) cohort (21.7 ± 2.4, p < 0.001).
• CTFC for RCA showed similar results with COVID (+) at 24.3 ± 4.5 and COVID (–) at 21.4 ± 2.5 (p < 0.001).
• Ongoing microvascular dysfunction is suggested in patients with a history of COVID-19.
• CSF is increasingly recognized as a significant clinical entity linked to cardiovascular risk.

Clinical Implications

Healthcare professionals should consider the history of COVID-19 in patients presenting with unstable angina and normal coronary arteries. Early identification of CSF may lead to tailored management strategies to mitigate cardiovascular risks in this population.

Conclusion

The study underscores the association between prior COVID-19 infection and increased prevalence of coronary slow flow, highlighting the need for ongoing monitoring and management of cardiovascular health in recovering patients.

Related Resources & Content

1. Frontiers in Cardiovascular Medicine, 2026 -- Coronary slow flow phenomenon: a meta-analysis of clinical risk predictors
2. Clinical Research in Cardiology, 2008 -- TIMI 3 Flow Following Primary Angioplasty as a Key Prognostic Indicator in Acute Myocardial Infarction Patients
3. Clinical Research in Cardiology, 2023 -- Gender-Based Variations in Sequential Alterations of Coronary Blood Flow and Microvascular Function in Patients with Suspected Angina
4. 2024 ESC Guidelines for Management of Chronic Coronary Syndromes: Key Points - American College of Cardiology
5. Long-Term Coronary Microvascular and Cardiac Dysfunction After Severe COVID-19 Hospitalization | JAMA Network
6. Basic Research in Cardiology — Impact of Elevated Heart Rate and Aortic Pressure on Baseline Measures of Functional Severity in Coronary Stenosis
7. 2024 ESC Guidelines for Management of Chronic Coronary Syndromes: Key Points - American College of Cardiology
8. Long-Term Coronary Microvascular and Cardiac Dysfunction After Severe COVID-19 Hospitalization | Coronavirus (COVID-19) | JAMA Network Open | JAMA Network
9. Coronary microvascular dysfunction in post-PCI target vessels: a systematic review and meta-analysis of prevalence and associated outcomes - PubMed